Why the study?
Does short term clarithromycin affect cardiovascular mortality in patients with stable coronary heart disease?
Population
Patients with stable coronary heart disease
Comparison
Short term clarithromycin vs Placebo
Design
RCT, Randomised, Placebo controlled
Authors
Loading...
Avoid short-term clarithromycin in stable CHD; challenges macrolide safety assumptions and extends caution to this population.
Does short term clarithromycin affect cardiovascular mortality in patients with stable coronary heart disease?
Short-term clarithromycin use in patients with stable coronary heart disease is associated with a safety signal of increased cardiovascular mortality.
Jespersen et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: